Test Microbiota Urinario
Test Microbiota Urinario

Urinary Microbiome Test Kit

€260,00

Required sample: first-void urine . Colli-Pee® device · stability 30 days at 20–26 °C · 

Reporting time: 3–4 weeks 

The Urinary Microbiome (Urobiome) test (€ 260.00) is a high-resolution molecular analysis that overcomes the traditional limitations of urine culture. By using the patented Colli-Pee® device for volumetric first-void urine sampling and WGS Shotgun Metagenomic sequencing technology on the Nanopore platform, the test detects bacteria (including anaerobes and fastidious species that cannot be cultured on plates), fungi, DNA viruses, antimicrobial resistance (AMR) genes, and virulence factors. A cutting-edge investigation for those suffering from discomfort or recurrent cystitis with negative traditional test results.

Test method

Informed consent

artt. 13 e 9 Reg. UE 2016/679 - GDPR

Required

Consent to the processing of health-related data for care purposes (section 3.a).

Required

Consent to receiving the service via teleconsultation, with the limits described in the notice.

Optional

Consent to possible recording of the session (not required for the service).

How does it work?

  • Collect the first urine stream with the Colli-Pee® device and complete the activation online via QR code.
  • Ship the sample: Place the tube in the kit using the included prepaid envelope. The preservative solution maintains stability at room temperature (20–26 °C) for up to 30 days, without the need for cold chain logistics.
  • Analysis and report: The laboratory performs DNA extraction and metagenomic shotgun sequencing; the interpreted report will be available online within 3–4 weeks.

Why choose?

  • Overcoming the limitations of urine culture: Urine is not sterile; metagenomic sequencing detects anaerobic, fastidious, or non-cultivable bacteria that traditional laboratory tests miss.
  • Broad-spectrum profiling: Simultaneously detects bacteria, fungi, DNA viruses, and genetic resistance determinants, providing a comprehensive overview of urinary tract biodiversity.
  • Maximum sampling efficiency: The same sample collected with the Colli-Pee® device allows for the integration of Sexually Transmitted Infection (STI) panels without the need for repeat sampling.
  • Optimized room-temperature storage: The Colli-Pee® device stabilizes the first-void urine fraction, ensuring biological data stability for 30 days without the need for a cold chain.

Who is it for?

  • Those experiencing frequent urinary tract episodes who wish to examine the composition of their urobiome as a supplement to traditional tests.
  • Those who wish to map microbial biodiversity in the presence of persistent discomfort already evaluated by a physician.
  • People with a history of frequent antibiotic or antifungal use who intend to verify the health of their urinary ecosystem.
  • Men who intend to monitor the microbial balance of their urogenital tract to support their well-being.
  • Urologists, gynecologists, and specialists who integrate metagenomic analysis into their clinical assessment pathways.

Disclaimer

  • Nature of the examination and medical non-substitutability: The test analyzes the composition of the urinary microbiome exclusively for informational, educational, and wellness support purposes. It does not constitute a direct clinical diagnosis, does not identify acute pathologies, and does not replace traditional urine cultures, physical-chemical urine examinations, or urological/gynecological visits prescribed by a physician.
  • Therapeutic planning and use of data: The information contained in the report, including the analysis of antimicrobial resistance (AMR) genes and virulence factors (VF), is for purely informational research/wellness purposes. It does not constitute a medical prescription or an indication for self-administration of medication (including antibiotics or antifungals). The evaluation of the data and any therapeutic management are the sole responsibility of the attending physician or specialist.
  • Temporary contraindications: To ensure the accuracy of the analysis, the test is not indicated if antibiotics or antifungal drugs have been taken in the previous 4 weeks. The waiting period extends to 8 weeks in the event of the intake of meropenem, gentamicin, or vancomycin.